FDA has issued a final rule requiring medical device manufacturers to electronically submit reports of adverse events associated with their products.

Meaningful Use and ICD-10 dominated the headlines again this week. It seems this could be the case most weeks this year.

Reston, VA, February 10, 2014 -- The Workgroup for Electronic Data Interchange (WEDI) in partnership with the Centers for Medicare and Medicaid Services (CMS), the Cooperative Exchange and other private industry partners, today announced the launch of its ICD-10 Success Initiative webinar series. The purpose of these webinars is to help health IT stakeholders meet the October 1 ICD-10 compliance deadline and to provide answers to common questions.

ICD-10 implementation will cost physicians “dramatically” more than previously estimated, according to a cost study initiated by the American Medical Association (AMA) and conducted by Nachimson Advisors.

Senators Deb Fischer (R-Neb.) and Angus King (I-Maine) announced legislation that would limit FDA’s regulatory oversight to focus on products that pose the greatest health risks.

The Centers for Medicare & Medicaid Services is giving eligible professionals an additional month to attest to Meaningful Use for the Medicare EHR incentive program 2013 reporting period. The announcement effectively pushes back the deadline from Feb. 28 to March 31.

Two of the biggest federal mandates facing providers this year were in the news this week—for good and bad reasons.

Clinical decision support, patient engagement, care coordination and population management are the four areas of special emphasis reflected in Meaningful Use Stage 3 draft recommendations, Paul Tang, MD, MS, Palo Alto Medical Foundation and chair of the MU workgroup, said at the Health IT Policy Committee meeting on Feb. 4.